Lipid nanoparticles composed of mixtures of PEGylated-lipids; cationic and neutral lipids prepared by detergent dialysis can encapsulate biological active molecules and show considerable potential as systemic therapeutic agents. Addition of biotinylated lipids to this formulation allows surface modifi cation of these particles with a suitable ligand or probe conjugated to streptavidin for specifi c cell targeting. Monitoring long circulating particles and cellular uptake requires stable and bright fl uorescent probes. Quantum dots (QDs) constitute a relatively new class of fl uorescent probes that overcome the limitations of organic fl uorophores in biological imaging applications. Here, a protocol for the encapsulation of QD 655 (red) in biotinylated lipid particles (BLPs) prepared by a detergent dialysis technique is presented followed by characterization of the loaded liposomal vehicles. Then, a protocol for BLPs surface modifi cation via biotin-streptavidin linkage with preformed complexes of ligand-QD 525 (green) for specifi c cell targeting of the nanoparticle is detailed. Conditions for cell binding and uptake of two colors QD labeled BLPs as well as basic microscopic settings for confocal live cell imaging are described.
Introduction
Liposomal carriers have become major tools for introducing not only a variety of nucleic acids but also proteins, peptides, and nanoparticles into cells in vitro and in vivo [ 1 ] . Lipid composition as well as the method of preparation will determine the average size of the carrier as well as the permeability through biological membranes, and thus the effi ciency of uptake by cells [ 2 , 3 ] . An important issue is the targeting of the carriers to specifi c cell types for which the delivery approach is intended. The role of receptors as molecular target has opened new opportunities for cellular or intracellular targeting using liposomal systems appended with appropriate ligands [ 4 ] .
Continuous cell imaging has been substantially improved with the introduction of fl uorescent probes such as quantum dots (QDs), colloidal nanocrystals composed of cadmium selenide (CdSe) or cadmium telluride (CdTe) core enclosed within a zinc sulfi de (ZnS) passivation shell [ 5 , 6 ] . The main advantages of QDs over organic fl uorophores are the greater photostability and the excitation wavelengths range that extends above 500 nm. The latter feature reduces cell phototoxicity, essential for long-term fl uorescence imaging. Whereas absorption spectra are broad, emission spectra are narrow without the extension to the red characteristic of organic dyes. This feature allows for simultaneous detection of multiple color QDs upon illumination with a single light source [ 7 ] .
We report here the preparation and characterization of BLPs, loaded with QD 655 and surface-modifi ed with preformed complexes of EGF-QD 525 (EGF, Epidermal Growth Factor) mediated by biotin-streptavidin linkage. The receptor specifi city of biotinylated EGF tagged with streptavidin coated QDs, has been extensively investigated in the laboratory, where this protocol was developed. EGF-QDs preformed complexes are biochemically competent ligands for erbB1, the EGF receptor [ 8 ] . BLPs were formulated containing up to 3 % of PEGylated-lipids to stabilize the lipid bilayer, and 2.7 % of fusogenic lipid in order to facilitate endosomal escape of loaded cargo into the cytoplasm. PEG (polyethylene glycol) content above 5 % may interfere for instance with the endocytic mechanism of uptake by either lowering the binding affi nity to cell receptors or by preventing the intermembrane contact between liposomal surface and endosomal membranes, required to release the cargo in the cytoplasm [ 9 ] . In the present protocol QDs loaded BLPs were prepared using a detergent dialysis technique [ 10 , 11 ] modifi ed for the encapsulation of 10 nm carboxyl-QD 655 (red) as an approach for delivering these fl uorescent nanoparticles into cells.
QD 655 loaded BLPs were purifi ed by ultracentrifugation in discontinuous sucrose gradient and then characterized according to size, QDs encapsulation effi ciency, and biotin incorporation.
Surface labeling and targeting of BLP-QD 655 were achieved by coupling preformed complexes of biotin-EGF with a second color of Streptavidin coated QD 525 (green) (Fig. 1 ) providing a monitoring tool for the specifi city of BLPs uptake and cargo release in live cells by confocal laser scan microscopy (CLSM). The two-color particles, hereafter referred to as EGF-QD 525 -BLP-QD 655 were targeted to A431 cells, a human epidermoid carcinoma cell line that overexpresses the EGF receptor. The rationale behind this twocolor labeling strategy is that only QD 525 and QD 655 that are colocalized would indicate the intracellular distribution of the targeted BLPs whereas time dependent loss of colocalization would suggest endosomal escape of QD 655 .
Materials
Prepare all solutions using sterile ultrapure water and analytical grade reagents. Manipulate lipids dissolved in chloroform under a fume hood until they are desiccated and transfer volumes employing appropriate Hamilton syringes, avoiding plastic lab-ware. Protect lipid solutions; BLPs and fl uorophores should be protected from direct light and maintain refrigerated.
1. Tyrode's buffer without glucose: 135 mM NaCl, 10 mM KCl, 0.4 mM MgCl 2 , 1 mM CaCl 2 , 10 mM of (2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), pH 7.2. Autoclave before use and store at room temperature (20-25 °C).
2. Tyrode's plus: add sterile solutions of 20 mM glucose and 0.2 % of bovine serum albumin (BSA) just before use.
3. HEPES buffered saline (HBS): 10 mM HEPES, 150 mM NaCl, pH 7.4. Sterilized by fi ltration through a 0.22 μm-poresize membrane.
Synthetic Lipids (Avanti Polar Lipids, Alabaster, AL, USA) were used as lyophilized powders or dissolved in chloroform and stored under argon in a desiccator at −20 °C. 10. Dialysis Cassette, Slide-A-Lyzer of 10 kDa cut-off for 0.5-3 mL sample (Pierce, Rockford, IL, USA).
11. SM-2 Biobeads with adsorbent capacity ~117 mg OGP/g beads (Bio-Rad, Hercules, CA, USA). 2. Coverslips, acid washed and sterilized.
3. Cell culture medium and antibiotics appropriate for the particular cell line.
Methods
1. Prepare BLPs formulation by mixing 8.4 μmols DOPE, 0.6 μmols DOTAP, 0.024 μmols Biotin-PEG-DSPE, and 0.25 μmols of PEG-750-Cer-C8 in 2 mL glass vials ( Fig. 2 ) ( see Note 3 ). In this step, and for any lipid variation in the original formulation, prepare a control of BLPs without QDs to check for vesicle formation during detergent dialysis.
Preparing Discontinuous Sucrose Gradient

Measuring Biotin
Dialyze lipids-detergent-QDs solution and control formulation without QDs against 1 L HBS for 3 h ( see Note 5 ).
6. Change buffer (1 L of HBS) and continue dialysis in a cold room (4-8 °C).
7. Carry out the last buffer change (third) adding polystyrene SM-2 Biobeads in the HBS buffer to minimize residual OGP content.
8. Recover the solution (~1 mL) from the dialysis cassette; this should not change at the end of dialysis. Keep on ice protected from light or in refrigerator while preparing the discontinuous sucrose density gradient ( see Note 6 ).
In order to separate QDs loaded BLPs from less dense empty BLPs and free non-encapsulated QDs, load the samples obtained after the detergent dialysis on top of a discontinuous sucrose density gradient and perform ultracentrifugation as described:
1. Cool the ultracentrifuge with swinging buckets to 10 °C and set speed to 160,000 × g .
2.
Prepare a discontinuous sucrose gradient in 2.5 mL ultraclear thin-wall centrifuge tubes by carefully applying with a tip or syringe, layers of 0.5 mL sterile sucrose solutions in HBS [ 12 ] . Two centrifuge tubes are required for loading the 1 mL sample recovered after detergent dialysis.
3. Add fi rst 0.5 mL of 2.5 % w/v sucrose solution, under this fraction pipette 0.5 mL of 10 % sucrose fraction and under this, the 20 % sucrose ( see Note 7 ). Carefully equilibrate the ultracentrifuge tubes by weight before adding dialysate containing the BLPs.
4. Add carefully 0.5 mL of the dialysate on top of the gradient by touching the internal wall of the tube over the 2.5 % sucrose band and place the ultracentrifuges tubes in the rotor with swinging buckets with the help of forceps. Carry out ultracentrifugation for 5 h at 10 °C.
5. After ultracentrifugation put the tubes in a transparent holder and briefl y illuminate with UV light to excite QD 655 fl uorescence. Three well-defi ned fl uorescent bands should be observed (Fig. 3 , panel a) . Mark with an indelible pen the QDs containing fractions.
6. Back in the bench, carefully recover sucrose fraction I ( see Note 8 ) then, recover the broader, turbid, and less intense fl uorescent band underneath (fraction II) enriched in BLP-QD 655 and fi nally the pellet with free non-encapsulated QD 655 (fraction III). 2. Select an operating protocol for spherical particles; applying 12-15 runs per measurement, depending on the instrument number of runs is automatically selected according to the concentration of particles in the sample.
Ultracentrifugation in
3. Perform three measurements on each sample and use the obtained intensity correlation data to calculate size distribution and average hydrodynamic diameter of the obtained BLPs. This can be achieved using the CONTIN algorithm [ 13 ] to fi t the autocorrelation data, this mathematical approach is recommended for hetero-and polydisperse systems ( see Notes 12 and 13 ).
Transmission Electron Microscopy (TEM) analysis of sucrose fraction II reveals an average of 2-5 QDs encapsulated in BLPs ranging from 100 to 130 nm in size (Fig. 3 , panel c) . Particle dimensions estimated from TEM are in agreement with the mean hydrodynamic diameter of ~110 nm as determined by DLS in the same fraction (Fig. 3 , panel b) .
Biotin content was quantifi ed using a fl uorometric assay with nanomolar sensitivity based on Foster resonance energy transfer (FRET) [ 14 ] . Briefl y, in the absence of biotin, HABA quenches the fl uorescence emission of the Alexa Fluor ® 488 dye via FRET. When biotin or a biotinylated molecule is added, HABA is displaced from the biotin binding sites resulting in an increase in the donor fl uorescence intensity proportional to the amount of biotin present in the sample. Biotin concentration allows an estimation of biotinylated lipid recovery relative to the molar amounts of biotinylated lipid initially added to the formulation; and has to be checked for each liposomal preparation after detergent dialysis and after purifi cation from sucrose gradient. 
Plot fl uorescence intensity at the emission maximum (519 nm)
as a function of biocytin concentration (nM) and fi t the data to a sigmoid curve to obtain the corresponding values for the unknown samples (Fig. 4 ) ( see Note 15 ).
BLPs-QDs Size Analysis
QD 655 Encapsulation Effi ciency
Biotin Incorporation into BLPs
The employed formulation of the streptavidin conjugated QDs contained an average of 6-8 covalently linked streptavidin molecules per QD molecule ( see Note 16 ). Coupling Biotin-EGF to Streptavidin-QD 525 at a ratio of 4:1 leaves free streptavidin in QDs for subsequent coupling to BLPs ( see Subheading 3.7 ).
1. Dilute biotin-EGF (or biotinylated ligand of interest) to 400 nM in HBS + 0.2 % BSA.
2. Dilute Streptavidin-QD 525 to 100 nM in HBS + 0.2 % BSA. 525 and biotinylated ligand with a micropipette.
Mix equal volumes of Streptavidin-QD
4. Incubate at 4 °C for at least 30 min with gentle agitation or rotation before coupling to BLPs. This mix should be used within 5 days to prevent deterioration of the peptidic ligand.
1. Adjust biotin concentration of BLPs-QD 655 to 1 μM and separate two aliquots of 150 μL.
Add 100 μL of preformed complexes of EGF-QD 525 to 150 μL
BLPs-QD 655 and incubate for at least 2 h at 15 °C with continuous shaking ( see Note 17 ).
3. In parallel, add 100 μL of HBS + 0.2 % BSA to 150 μL BLPs-QD 655 and incubate for at least 2 h at 15 °C with continuous shaking.
1. Plate cells in culture dishes containing sterile glass coverslips or in glass bottom culture chambers suitable for fl uorescence confocal microscopy.
2. Grow A431 cells or the selected cells expressing the receptor of interest in complete culture medium with antibiotics at the appropriate densities 1 or 2 days prior to the experiment. 9. Place the cell chamber on the microscope stage pre-equilibrated to 37 °C.
10. After initial binding (within 5 min) at 37 °C, take a snapshot; carefully remove excess of BLPs solution, BLPs in suspension will contribute to background fl uorescence.
11. Add 500 μL of warm Tyrode's plus buffer and start a time lapse imaging acquiring every 5 min during 30 min or until endocytic uptake of the BLPs is evident ( see Note 18 ).
When employing a different biotinylated ligand specifi c receptor targeting should be tested in the presence of soluble excess ligand and/or using cells devoid of the receptor of interest [ 15 ] and optimal concentrations of ligands has to be checked according to the binding constant for stimulated uptake of specifi c receptors. Residual free preformed complexes (EGF-QD 525 ) were expected to bind to EGF receptors (Fig. 5 ).
1. Begin acquisition of a time series with single or multiple focal planes (z-stack). Typically, a 63× or 40× 1.2 numerical aperture (NA) water immersion objective is recommended.
2. Simultaneous excitation of QD 525 and QD 655 can be achieved at 488 nm employing an imaging system with two detectors, e.g., Zeiss LSM 510 META, with appropriate fi lters (in this case, 520/20 band-pass and 585 long-pass, respectively ( see Note 19 )).
3. For visual analysis of BLPs internalization, subtract background from each channel and to every single focal plane of a z-stack at each time point. Then, reconstruct the 3D image and merge both channels to look for colocalization.
Simultaneous Detection of Two Different Colors of QDs and Colocalization Analysis
Select z-stack at t = 0 min, when BLPs are bound but not internalized and then select z-stacks after 5, 10, 15, 20, and 30 min (end point) imaging at room temperature (20-25 °C). Additionally, 2D representations of 3D cells can be created from maximum intensity projections of several slices in the z-dimension, excluding the top and bottom planes of all cells in the microscopic fi eld.
4. Analyze colocalization of both QDs in background-corrected images of single focal intracellular planes (not projections) by presenting a plate of three images, two corresponding to the 
Notes
1. Thaw 20 % sterile sucrose solution in the refrigerator and mix well until the solution appears homogeneous before proceeding with subsequent dilutions. Is preferable to prepare multiple aliquots of the stock and use one for each gradient to prevent bacterial contamination.
2. For this purpose we employed Beckman ultraclear thin-wall centrifuge tubes in TL-100 Beckman ultracentrifuge and rotor TLS 55 with swinging buckets.
3. If lipids are obtained as lyophilized powders, dissolve fi rst each lipid in chloroform and transfer volumes with Hamilton syringe or glass pipettes, avoid plastic tips during this step, contaminants could be extracted by chloroform and micropipette can be damaged as well.
4. Commercially obtained QDs solution should be homogeneous and free of aggregates. Number of streptavidins conjugated to QDs has to be check for each lot number of the product from the selected supplier.
5. Visible turbidity should be detected within the fi rst hour of dialysis, indicating the formation of self-assembled lipid-QDs particles. The particles should remain in solution without forming aggregates. Empty self-assembled BLPs are smaller ~50-70 nm size and their true presence has to be checked by DLS.
6. BLP-QD 655 cannot be frozen due to irreversibly QDs fl uorescence quenching and destabilization of BLPs bilayer and should be stored refrigerated (4-8 °C), for storage periods longer than a week, BLPs solution should be fi lter-sterilized through 0.22 μm pore size. However, this step results in considerable sample loss.
7. Use a syringe with long needle to load the solutions at the bottom of the tubes. Clear lines between the layers should be seen, indicating that minimal mixing has occurred.
8. Sucrose fraction I, may contain QD loaded BLPs but it is enriched in free lipids and empty vesicles and is not further employed.
9. Sucrose does not interfere with DLS measurements, biotin quantitation, or subsequent BLPs labeling. However, is susceptible of bacterial contamination. Alternatively, samples can be dialyzed against 2 L of sterile HBS to minimize sucrose content before particle analysis.
10. Signifi cant sample loss occurs during fi ltering. In our experience, using sterile solutions and labware during BLPs preparation and working under a laminar fl ow during cell targeting allowed us to perform BLPs binding and uptake experiments for up to 24 h in the presence of antibiotics with occasional contamination.
11. DLS measurements were performed with ZetaSizer Nano from Malvern Instruments. Samples were diluted in phosphate buffered saline (PBS) and measurements performed at room temperature (20-25 °C). The PBS used to dilute the samples was previously fi ltered through 0.02 μm pore size to eliminate potential interfering impurities.
12. The mean hydrodynamic diameter of a population of particles calculated by Dynamic light scattering involves the determination of how the intensity of the light scattered by a solution of moving particles varies with time. This variation is correlated with the speed at which particles move, which can be characterized by their diffusion coeffi cients [ 17 ] . The average hydrodynamic diameter of particles is obtained from the diffusion coeffi cients.
13. The average hydrodynamic diameter represents only an intensity-based average value and does not give any information on the prevailing size distribution. For this reason, the polydispersity index (pdi) is also stated to give information about the actual distortion of a monomodal distribution. The pdi can have values between 0 and 1 and is equivalent to the variance σ 2 of the size distribution. BLPs preparations with pdi <0.25 were considered as monodisperse solutions and further characterized.
14. It is convenient to test several dilutions in duplicate of BLPs to obtain an accurate biotin concentration, high concentration of BLPs particles may also interfere in biotin quantitation due light scattering.
15. In the conditions assayed a ~6-fold increase in fl uorescence signal upon complete displacement of HABA was observed with a detection limit of approximately 3 nM biocytin. Standard colorimetric HABA assay can be performed for samples containing above 10 μM biotin.
16. Previous control experiments are necessary to establish that streptavidin-QDs does not interfere with the normal biological function of the selected biotin-ligand [ 18 ] .
17. Although increasing the number of EGF ligands per particle should in principle improve the binding to cells and increase the number of internalized particles, larger size of the carrier would probably interfere with the receptor-mediated endocytosis [ 19 ] .
18. A431 cells are maintained healthy in Tyrode's plus for up to 30 min at 37 °C. However, for longer incubations Tyrode's buffer should be replaced by phenol free culture medium and imaging performed under oxygen-controlled atmosphere. The labeled and targeted BLPs can be continuously monitored using confocal microscopy during cell binding and uptake for periods longer than 1 h without signifi cant photobleaching highlighting the convenience of QDs as labeling probes for long-term imaging of dynamic processes. However, cell phototoxicity cannot be overlooked.
19. Within the given settings, channel cross-talk was negligible as determined using single-labeled samples.
20. Manders' coeffi cients are proportional to the fraction of fl uorescence of the colocalizing fl uorophores in each channel of the composite image, i.e., relative to the total fl uorescence in that channel. These coeffi cients are more appropriate when signal intensities in the two image channels have signifi cant different levels.
